Evogliptin is indicated for the treatment of type 2 diabetes mellitus in adults.
-The dosage of evogliptin can vary, and it is typically prescribed by a healthcare professional. Patients should follow the prescribed dosage and administration instructions provided by their healthcare provider. -Oral; 100mg twice a day.
-Evogliptin may be contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Contraindications may also include certain medical conditions, and it is essential for individuals to inform their healthcare provider of their complete medical history. -Hypersensitivity
-Special precautions should be taken in individuals with pre-existing medical conditions such as kidney impairment. It is important for healthcare providers to assess the patient's overall health and determine the suitability of evogliptin for their specific case. Paediatric: Safety and efficacy in pediatric patients have not been established Pregnancy: Data not sufficient Lactation: Data not sufficient Elderly: Data not sufficient
-Common side effects of evogliptin may include headache, upper respiratory tract infection, and gastrointestinal symptoms. However, individual responses may vary, and patients should report any unusual or severe side effects to their healthcare provider. -Low blood sugar (hypoglycemia), Urinary tract infections, Nervousness or anxiety, Irritability to sweat, Weight loss, Dizziness or headache, Fatigue, genital fungal infection
-Evogliptin may interact with other medications, and it is important to inform the healthcare provider of all medications, including over-the-counter and herbal supplements, being taken concurrently. -Other hypoglycemic drugs
|CARDIMIND PHARMACEUTICALS (A Division of Asterisk Laboratories Pvt Ltd)